{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:31:13Z","timestamp":1778999473677,"version":"3.51.4"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p><jats:italic>Streptococcus pneumoniae<\/jats:italic> is one of the leading bacterial pathogens that can cause severe invasive diseases. The aim of the study was to characterize invasive isolates of <jats:italic>S. pneumoniae<\/jats:italic> obtained during the nine-year period in Serbia before the introduction of the pneumococcal conjugate vaccines (PCVs) into routine vaccination programs by determining: serotype distribution, the prevalence and genetic basis of antimicrobial resistance, and genetic relatedness of the circulating pneumococcal clones. A total of 490 invasive <jats:italic>S. pneumoniae<\/jats:italic> isolates were included in this study. The serotype, antimicrobial susceptibility, and ST of the strains were determined by the Quellung reaction, disk- and gradient-diffusion methods, and multilocus sequence typing (MLST), respectively. The most common serotypes in this study were 3, 19F, 14, 6B, 6A, 19A, and 23F. The serotype coverages of PCV10 and PCV13 in children less than 2\u2009years were 71.3 and 86.1%, respectively, while PPV23 coverage in adults was in the range of 85-96%, depending on the age group. Penicillin and ceftriaxone-non-susceptible isolates account for 47.6 and 16.5% of all isolates, respectively. Macrolide non-susceptibility was detected in 40.4% of isolates, while the rate of multidrug- and extensive-drug resistance was 20.0 and 16.9%, respectively. The MLST analysis of 158 pneumococci identified 60 different STs belonging to the 16 Clonal Complexes (CCs) (consisting of 42 STs) and 18 singletons. The most common CC\/ST were ST1377, CC320, CC15, CC273, CC156, CC473, CC81, and CC180. Results obtained in this study indicate that the pre-vaccine pneumococcal population in Serbia is characterized by high penicillin and macrolides non-susceptibility, worrisome rates of MDR and XDR, as well as a high degree of genetic diversity. These findings provide a basis for further investigation of the changes in serotypes and genotypes that can be expected after the routine introduction of PCVs.<\/jats:p>","DOI":"10.3389\/fmicb.2023.1244366","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T14:20:56Z","timestamp":1692627656000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Serotype distribution, antimicrobial susceptibility and molecular epidemiology of invasive Streptococcus pneumoniae in the nine-year period in Serbia"],"prefix":"10.3389","volume":"14","author":[{"given":"Natasa","family":"Opavski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milos","family":"Jovicevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovana","family":"Kabic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusan","family":"Kekic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zorica","family":"Vasiljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Tosic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deana","family":"Medic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana","family":"Laban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazar","family":"Ranin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Gajic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.3390\/microorganisms10122316","article-title":"An overview of macrolide resistance in streptococci: prevalence, mobile elements and dynamics","volume":"10","author":"Berbel","year":"2022","journal-title":"Microorganisms"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ijantimicag.2011.01.019","article-title":"Mef(a) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany","volume":"37","author":"Bley","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref4","article-title":"Pneumococcal disease surveillance reporting and trends | CDC","year":"2019"},{"key":"ref5","article-title":"Global pneumococcal disease and vaccination | CDC","year":"2020"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3201\/eid1402.070807","article-title":"Streptococcus pneumoniae serotype 19A in children, South Korea","volume":"14","author":"Choi","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"ref7","first-page":"13","article-title":"Antimicrobial resistance among Streptococcus pneumoniae","author":"Cill\u00f3niz","year":"2018"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(08)70281-0","article-title":"Impact of conjugate pneumococcal vaccines on antibiotic resistance","volume":"8","author":"Dagan","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1016\/J.VACCINE.2015.04.005","article-title":"Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada","volume":"33","author":"Deceuninck","year":"2015","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3390\/diagnostics11061059","article-title":"A Laboratory-based surveillance study of invasive Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae diseases in a Serbian Pediatric population\u2014implications for vaccination","volume":"11","author":"Delic","year":"2021","journal-title":"Diagnostics"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3201\/eid2808.212440","article-title":"Characterization of emerging serotype 19A pneumococcal strains in invasive disease and carriage, Belgium","volume":"28","author":"Desmet","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S2213-2600(14)70060-8","article-title":"Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study","volume":"2","author":"Domingues","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"ref13","article-title":"Invasive pneumococcal disease \u2013 Annual Epidemiological Report for 2018","year":"2018"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jiph.2016.11.014","article-title":"Molecular detection of genes responsible for macrolide resistance among Streptococcus pneumoniae isolated in North Lebanon","volume":"10","author":"El Ashkar","year":"2017","journal-title":"J. Infect. Public Health"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1099\/00221287-144-11-3049","article-title":"A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease","volume":"144","author":"Enright","year":"1998","journal-title":"Microbiology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijantimicag.2007.10.022","article-title":"Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT year 5 (2003\u20132004)","volume":"31","author":"Farrell","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1128\/JB.186.5.1518-1530.2004","article-title":"eBURST: inferring patterns of evolutionary descent among clusters of related Bacterial genotypes from multilocus sequence typing data","volume":"186","author":"Feil","year":"2004","journal-title":"J. Bacteriol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2298\/SARH1302048G","article-title":"Invasive isolates of Streptococcus pneumoniae in Serbia: antimicrobial susceptibility and serotypes","volume":"141","author":"Gajic","year":"2013","journal-title":"Srp. Arh. Celok. Lek."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1128\/jcm.32.5.1308-1311.1994","article-title":"Detection of Streptococcus pneumoniae in sputum samples by PCR","volume":"32","author":"Gillespie","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0120290","DOI":"10.1371\/JOURNAL.PONE.0120290","article-title":"Impact of ten-Valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children \u2013 a population-based study","volume":"10","author":"Jokinen","year":"2015","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.12688\/WELLCOMEOPENRES.14826.1","article-title":"Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications","volume":"3","author":"Jolley","year":"2018","journal-title":"Wellcome Open Res."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/infdis\/jiu552","article-title":"Evidence for clonal expansion after antibiotic selection pressure: pneumococcal multilocus sequence types before and after mass azithromycin treatments","volume":"211","author":"Keenan","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e1003326","DOI":"10.1371\/JOURNAL.PMED.1003326","article-title":"Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: a case-control test-negative design study","volume":"17","author":"Lawrence","year":"2020","journal-title":"PLoS Med."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jmii.2020.01.003","article-title":"The antimicrobial susceptibility in adult invasive pneumococcal disease in the era of pneumococcus vaccination: a hospital-based observational study in Taiwan","volume":"53","author":"Lee","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/FCIMB.2019.00407","article-title":"Serotype distribution, antimicrobial susceptibility, and multilocus sequencing type (MLST) of Streptococcus pneumoniae from adults of three hospitals in Shanghai, China","volume":"9","author":"Li","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S1473-3099(19)30297-X","article-title":"Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study","volume":"19","author":"Lo","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"100.e1","DOI":"10.1016\/J.AMJMED.2017.06.039","article-title":"Effect of age on the manifestations and outcomes of invasive pneumococcal disease in adults","volume":"131","author":"Marrie","year":"2018","journal-title":"Am. J. Med."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"O255","DOI":"10.1111\/1469-0691.12373","article-title":"Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories","volume":"20","author":"Matuschek","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1099\/jmm.0.001151","article-title":"Phenotypic and molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae isolated in Tunisia","volume":"69","author":"Midouni Ayadi","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"ofac420","DOI":"10.1093\/ofid\/ofac420","article-title":"A Multicenter evaluation of trends in antimicrobial resistance among Streptococcus pneumoniae isolates from adults in the United States","volume":"9","author":"Mohanty","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00508-015-0721-y","article-title":"Serotypes and genotypes of invasive pneumococci in the central part of Slovenia","volume":"127","author":"M\u00fcller Premru","year":"2015","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1128\/AAC.46.2.371-377.2002","article-title":"Susceptibilities to Telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 central and eastern European countries","volume":"46","author":"Nagai","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e107666","DOI":"10.1371\/journal.pone.0107666","article-title":"Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines","volume":"9","author":"Ndlangisa","year":"2014","journal-title":"PLoS One"},{"key":"ref37","volume-title":"Bacterial meningitis in the Netherlands: annual report 2013","year":"2014"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/S00431-013-2193-2","article-title":"Characteristics of invasive pneumococcal disease in hospitalized children in Austria","volume":"173","author":"Paulke-Korinek","year":"2014","journal-title":"Eur. J. Pediatr."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999\u201320111","volume":"19","author":"Richter","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14760584.2021.1873136","article-title":"Circulating clonal complexes and sequence types of Streptococcus pneumoniae serotype 19a worldwide: the importance of multidrug resistance: a systematic literature review","volume":"20","author":"Ruiz Garc\u00eda","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1179\/1120009X12Z.0000000004","article-title":"Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Bulgaria before the introduction of pneumococcal conjugate vaccine","volume":"24","author":"Setchanova","year":"2012","journal-title":"J. Chemother."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jgar.2018.05.012","article-title":"Rise of multidrug-resistant Streptococcus pneumoniae clones expressing non-vaccine serotypes among children following introduction of the 10-valent pneumococcal conjugate vaccine in Bulgaria","volume":"15","author":"Setchanova","year":"2018","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/genes10090687","article-title":"The genomics of Streptococcus pneumoniae carriage Isolates from UK children and their household contacts, pre-PCV7 to post-PCV13","volume":"10","author":"Sheppard","year":"2019","journal-title":"Genes"},{"key":"ref01","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1128\/AAC.01464-08","article-title":"Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006","volume":"53","author":"Siira","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/9781555816728.ch20","article-title":"Streptococcus","volume-title":"Manual of clinical microbiology","author":"Spellerberg","year":"2011"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1038\/s41598-019-39791-1","article-title":"Identification of Streptococcus pneumoniae by a real-time PCR assay targeting SP2020","volume":"9","author":"Tavares","year":"2019","journal-title":"Sci. Rep."},{"key":"ref48","article-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 12.0","year":"2022"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/antibiotics10040397","article-title":"Increase and change in the pattern of antibiotic use in Serbia (2010\u20132019)","volume":"10","author":"Tomas","year":"2021","journal-title":"Antibiotics"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the global burden of disease study 2015","volume":"17","author":"Troeger","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type B disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob. Heal."},{"key":"ref14","volume-title":"Antimicrobial resistance surveillance in Europe 2022 \u2013 2020 data","year":"2022"},{"key":"ref52","article-title":"Considerations for pneumococcal conjugate vaccine (PCV) product choice","year":"2021"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1244366\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T14:21:00Z","timestamp":1692627660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1244366\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":49,"alternative-id":["10.3389\/fmicb.2023.1244366"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1244366","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"article-number":"1244366"}}